A carregar...

Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results

PURPOSE: Combinations of long-acting bronchodilators are recommended to reduce the rate of COPD exacerbations. Evidence from the DYNAGITO trial showed that the fixed-dose combination of tiotropium + olodaterol reduced the annual rate of total exacerbations (P<0.05) compared with tiotropium monoth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Chron Obstruct Pulmon Dis
Main Authors: Hoogendoorn, Martine, Corro Ramos, Isaac, Baldwin, Michael, Luciani, Laura, Fabron, Cecile, Detournay, Bruno, Rutten-van Mölken, Maureen P M H
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6388779/
https://ncbi.nlm.nih.gov/pubmed/30863045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S191031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!